Determinants of High Facility Costs in Total Joint Arthroplasty Patients: A Time-driven Activity-based Costing Analysis
Authors:
- Juan D. LizcanoJLJuan D. Lizcano
- Graham S. GohGGGraham S. Goh
- Saad TarabichiSTSaad Tarabichi
- P. Maxwell CourtneyPCP. Maxwell Courtney
- 26 June 2023
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of the American Academy of Orthopaedic Surgeons
- Vol. 31 (19) , e824-e833
Abstract
Introduction: Although several studies identify risk factors for high-cost patients in an episode of care for total hip (THA) and knee arthroplasty (TKA), few have looked at cost outliers from a facility perspective. The purpose of this study was to use time-driven activity-based costing (TDABC) to identify characteristics of high-cost patients. Methods: We reviewed a consecutive series of primary THA and TKA patients by 22 different surgeons at two hospitals between 2015 and 2020. Facility costs were calculated using a TDABC algorithm for their entire hospital stay. Patients in the top decile of costs were considered to be high-cost patients. Multivariate regression was done to identify independent patient factors that predicted high costs. Results: Of the 8,647 patients we identified, 60.5% underwent THA and 39.5% underwent TKA. Implant purchase price accounted for 49.5% of total inpatient costs (mean $2,880), followed by intraoperative (15.9%, mean $925) and postoperative personnel costs (16.8%, mean $980). Implant price demonstrated the highest variation between high-cost and low-cost groups (4.4 times). Patient-related factors associated with high costs were female sex (OR = 1.332), Hispanic ethnicity (OR = 1.409), American Society of Anesthesiology score (OR = 1.658), need for transfusion (OR = 2.008), and lower preoperative HOOS/KOOS Jr (OR = 1.009). Conclusion: This study identifies several variables for patients at risk to have high facility costs after primary THA and TKA. From the hospital's perspective, efforts to reduce implant purchase prices may translate into substantial cost savings. At the patient level, multidisciplinary initiatives to optimize medical comorbidities, decrease transfusion risk, and control medication expenses in high-risk patients may narrow the existing variation in costs.Keywords
This publication has 32 references indexed in Scilit:
- The Use of Porous Tantalum Augments for the Reconstruction of Acetabular Defect in Primary Total Hip ArthroplastyThe Journal of Arthroplasty, 2018
- Effects of the Length of Stay on the Cost of Total Knee and Total Hip Arthroplasty from 2002 to 2013Journal of Bone and Joint Surgery, 2017
- Time-driven Activity-based Costing More Accurately Reflects Costs in Arthroplasty SurgeryClinical Orthopaedics and Related Research, 2016
- The difficult primary total knee arthroplastyThe Bone & Joint Journal, 2015
- Preoperative Anemia Increases Postoperative Complications and Mortality Following Total Joint ArthroplastyThe Journal of Arthroplasty, 2015
- Decreasing Total Joint Implant Costs and Physician Specific Cost Variation Through NegotiationThe Journal of Arthroplasty, 2014
- Role of preoperative anemia for risk of transfusion and postoperative morbidity in fast‐track hip and knee arthroplastyTransfusion, 2013
- Sex differences in pain: a brief review of clinical and experimental findingsBritish Journal of Anaesthesia, 2013
- Contribution of Preventable Acute Care Spending to Total Spending for High-Cost Medicare PatientsJAMA, 2013
- Do “Premium” Joint Implants Add Value?: Analysis of High Cost Joint Implants in a Community RegistryClinical Orthopaedics and Related Research, 2011